Latest News

• share
• favorite_border

The American Academy of Microbiology has elected Florian Krammer, PhD, Mount Sinai Professor in Vaccinology, and Gustavo Palacios, PhD, Professor of Microbiology at the Icahn School of Medicine at Mount Sinai, along with 63 peers to its Class of 2023 fellows. Fellows of the American Academy of Microbiology, an honorary leadership group and a think tank within the American Society for Microbiology (ASM), are elected annually through a highly selective peer-review process based on their records of scientific achievement and original contributions that have advanced microbiology.

• share
• favorite_border

Immunotherapy after surgery increased bladder cancer patients’ chance of staying cancer-free compared to patients who received a placebo, according to clinical trial results shared in a late-breaking oral presentation at the American Society of Clinical Oncology (ASCO) 2023 Genitourinary Cancers Symposium in February.

• share
• favorite_border

• share
• favorite_border

Researchers Develop One of the First Screening Methods Using Wearables During Sleep to Predict and Detect the Onset of Parkinson’s Disease

• share
• favorite_border

• share
• favorite_border

The Arnhold Institute for Global Health at Mount Sinai has received $8 million from the Arnhold Foundation, enabling doctors, researchers, and students to advance its already-strong base of clinical education programs, training, research, and care services to address the world’s leading health issues and improve global health systems.

• share
• favorite_border

High-risk pregnancy specialists available for interview about new studies and other maternal-fetal health topics

• share
• favorite_border

Notalgia paresthetica is a common and underdiagnosed condition characterized by a persistent itch in the upper back. To date, there are no FDA-approved treatments specifically targeting this disorder. But a new study, published in the NEJM, suggests that patients with the disorder could potentially get relief with oral difelikefalin.

• share
• favorite_border

Medical students at the Icahn School of Medicine at Mount Sinai are challenging a traditional model of medical education they say omits a critical ingredient: preparing students for the experience of segregation within health care.

• share
• favorite_border

• share
• favorite_border

Seeking to address racism and bias against Asian Americans and Pacific Islanders (AAPI), as well as the under-representation of AAPI in leadership roles in medicine, Mount Sinai announced today the launch of the Center for Asian Equity and Professional Development (CAEPD). This innovative undertaking represents one of the first of its kind nationwide by an academic medical center.

• share
• favorite_border

The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai is delighted to announce a $5 million bequest promised by Kenneth L. Edelson, MD, Clinical Professor of Dermatology.

• share
• favorite_border

Doctors warn about lack of knowledge of administering CPR, especially in high-risk groups, and the rise of stress-related heart issues

• share
• favorite_border

The Dubin Breast Center of The Tisch Cancer Institute at the Mount Sinai Health System celebrated its 12th anniversary with its annual gala on Monday, December 12.

• share
• favorite_border

Researchers at The Tisch Cancer Institute at Mount Sinai have identified a treatment that is effective and safer than the standard of care for a serious, and sometimes fatal, side effect of bone marrow transplant in cancer patients. Results from a phase 2 clinical trial were presented at the annual meeting of the American Society of Hematology (ASH) in December.

• share
• favorite_border

A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

• share
• favorite_border

Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped

• share
• favorite_border

As medical schools across the country grapple with the arduous process of revising their curricula to be anti-racist, students at the Icahn School of Medicine at Mount Sinai have turned a critical eye on the very textbooks that have trained medical students for years.

• share
• favorite_border

Unique program keeps patients with less severe conditions out of the Emergency Department, saving them time and money

• share
• favorite_border

Researchers at The Tisch Cancer Institute uncovered inflammatory markers that may predict which COVID-19 patients are more likely to respond to therapies like the anti-cancer drug pacritinib, according to phase 2 trial results published in JAMA Network Open in December.

• share
• favorite_border

Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces the publication of new real-world evidence (RWE) in Primary Care and Community Health demonstrating the Company’s KidneyIntelX bioprognostic™ test resulted in changed clinical decision making for patients in the early-stage of diabetic kidney disease (DKD) being cared for within the Mount Sinai Health System’s Population Health Ambulatory Pharmacy and Condition Management programs.

• share
• favorite_border

The Icahn School of Medicine at Mount Sinai announced today the appointment of two new Laureates as part of its Biomedical Laureates Program, bringing the total to five appointments for this year and furthering its institutional commitment to broadening faculty diversity and mentorship opportunities.

• share
• favorite_border

Diagnosing early-stage lung cancer with low-dose computed tomography (CT) screening drastically improves the survival rate of cancer patients over a 20-year period, according to a large-scale international study being presented by Mount Sinai researchers at the annual meeting of the Radiological Society of North America.

• share
• favorite_border

The polycystic kidney disease (PKD) Foundation—the only organization in the U.S. dedicated solely to finding treatments and a cure for PKD recently named Mount Sinai Health System as a PKDF Partner Clinic for their desire to support patients with Autosomal Dominant PKD (ADPKD).

• share
• favorite_border

The Mount Sinai Health System has officially unveiled its new, state-of-the-art Mount Sinai Phillips School of Nursing (PSON) campus, located at 126th Street and Lexington Avenue.

• share
• favorite_border

A team of geriatricians at Mount Sinai’s Brookdale Department of Geriatrics and Palliative Medicine has been awarded $1.25 million from the Health Resources and Services Administration and the Keith Haring Foundation to expand Mount Sinai’s interdisciplinary model of care for older patients living with HIV.